Department of Cardiology, Haga Hospital, The Hague, the Netherlands.
Neth Heart J. 2010 Jan;18(1):31-7.
New developments and expanding indications have resulted in a significant increase in the number of patients with pacemakers and internal cardioverterdefibrillators (ICDs). Because of its unique capabilities, magnetic resonance imaging (MRI) has become one of the most important imaging modalities for evaluation of the central nervous system, tumours, musculoskeletal disorders and some cardiovascular diseases. As a consequence of these developments, an increasing number of patients with implanted devices meet the standard indications for MRI examination. Due to the presence of potential life-threatening risks and interactions, however, pacemakers and ICDs are currently not approved by the Food and Drug Administration (FDA) for use in an MRI scanner. Despite these limitations and restrictions, a limited but still growing number of studies reporting on the effects and safety issues of MRI and implanted devices have been published. Because physicians will be increasingly confronted with the issue of MRI in patients with implanted devices, this overview is given. The effects of MRI on an implanted pacemaker and/or ICDs and vice versa are described and, based on the current literature, a strategy for safe performance of MRI in these patients is proposed. (Neth Heart J 2010;18:31-7.).
新的发展和不断扩大的适应证使得植入起搏器和植入式心脏复律除颤器（ICD）的患者数量显著增加。由于其独特的功能，磁共振成像（MRI）已成为评估中枢神经系统、肿瘤、肌肉骨骼疾病和某些心血管疾病的最重要的成像方式之一。由于这些发展，越来越多的植入设备患者符合 MRI 检查的标准适应证。然而，由于存在潜在的危及生命的风险和相互作用，起搏器和 ICD 目前未获得美国食品和药物管理局（FDA）批准可在 MRI 扫描仪中使用。尽管存在这些限制和限制，但仍有一些关于 MRI 和植入设备的影响和安全性问题的研究报告发表，尽管数量有限，但仍在不断增加。由于医生将越来越多地面对植入设备患者的 MRI 问题，因此提供了这篇综述。描述了 MRI 对植入起搏器和/或 ICD 的影响，反之亦然，并根据当前文献提出了在这些患者中安全进行 MRI 的策略。（Neth Heart J 2010;18:31-7.）。
